Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma

Epstein–Barr virus (EBV) was the first tumor virus in humans. Nasopharyngeal carcinoma (NPC) accounts for approximately 60% of the 200,000 new tumor cases caused by EBV infection worldwide each year. NPC has an insidious onset and is highly malignant, with more than 70% of patients having intermedia...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenting, Duan, Xiaobing, Chen, Xingxing, Zhan, Meixiao, Peng, Haichuan, Meng, Ya, Li, Xiaobin, Li, Xian-Yang, Pang, Guofu, Dou, Xiaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875085/
https://www.ncbi.nlm.nih.gov/pubmed/36713430
http://dx.doi.org/10.3389/fimmu.2022.1079515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875085/
https://www.ncbi.nlm.nih.gov/pubmed/36713430
http://dx.doi.org/10.3389/fimmu.2022.1079515

Ejemplares similares